EXACT Sciences Corp. (EXAS)

97.54
2.20 2.20
NASDAQ : Health Technology
Prev Close 99.74
Open 99.02
Day Low/High 97.47 / 99.70
52 Wk Low/High 53.06 / 123.99
Volume 1.21M
Avg Volume 1.82M
Exchange NASDAQ
Shares Outstanding 129.49M
Market Cap 12.28B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Netflix, iRobot, Exact Sciences: 'Mad Money' Lightning Round

Netflix, iRobot, Exact Sciences: 'Mad Money' Lightning Round

Jim Cramer weighs in on Netflix, iRobot, Exact Sciences, Rite Aid, Inmode and more.

Stocks Get Whiplash: Cramer's 'Mad Money' Recap (Tuesday 10/1/19)

Stocks Get Whiplash: Cramer's 'Mad Money' Recap (Tuesday 10/1/19)

Jim Cramer says that while recession fears hit stocks Tuesday, he thinks there are other rational reasons for the pullback.

Exact Sciences: Finding the Exact Price to Buy the Stock

Exact Sciences: Finding the Exact Price to Buy the Stock

Let's check the charts and indicators to see if this a good time and location to go long EXAS.

PayPal, NextEra Energy, Sarepta Therapeutics: 'Mad Money' Lightning Round

PayPal, NextEra Energy, Sarepta Therapeutics: 'Mad Money' Lightning Round

Jim Cramer takes a look at PayPal, NextEra Energy, Sarepta Therapeutics, CEL-SCI, MFA Financial, Fidelity National Services and more.

Exact Sciences Lifted to Buy at Benchmark on Wider Cologuard-Use Approval

Exact Sciences Lifted to Buy at Benchmark on Wider Cologuard-Use Approval

Analyst Bruce Jackson likes the prospects for the producer of a DNA-based colon-cancer-screening test for use at home.

Cologuard® Gains FDA Approval For Use In Younger Americans, Ages 45 To 49

Cologuard® Gains FDA Approval For Use In Younger Americans, Ages 45 To 49

Stool DNA test offers a sensitive, noninvasive, at-home option to screen for colorectal cancer, second deadliest cancer in U.S.

Exact Sciences Named One Of The 2019 Best Workplaces For Women By Great Place To Work® And FORTUNE

Exact Sciences Named One Of The 2019 Best Workplaces For Women By Great Place To Work® And FORTUNE

Open jobs offer opportunity to join dynamic company

Notable Wednesday Option Activity: EXAS, AMBC, HD

Notable Wednesday Option Activity: EXAS, AMBC, HD

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in EXACT Sciences Corp. , where a total of 6,258 contracts have traded so far, representing approximately 625,800 underlying shares.

Cologuard® Helps More People Get Screened In A Cost-Effective Way

Cologuard® Helps More People Get Screened In A Cost-Effective Way

ABOUT HALF OF THOSE TESTED WITH COLOGUARD WERE PREVIOUSLY UNSCREENED

Exact Sciences To Participate In September Investor Conference

Exact Sciences To Participate In September Investor Conference

MADISON, Wis., Aug.

Exact Sciences To Participate In August Investor Conference

Exact Sciences To Participate In August Investor Conference

MADISON, Wis., Aug.

Short-Seller Left Goes Long on Invitae With $100 Target

Short-Seller Left Goes Long on Invitae With $100 Target

Citron analyst sees 'indestructible moat' around genetic-testing company's business.

Exact Sciences Is Poised to Test New Highs on the Charts

Exact Sciences Is Poised to Test New Highs on the Charts

Here's how to trade the stock right now.

Don't Fight the Fed: Cramer's 'Mad Money' Recap (Monday 7/29/19)

Don't Fight the Fed: Cramer's 'Mad Money' Recap (Monday 7/29/19)

Jim Cramer talks about what investors need to do ahead of an expected rate cut and amid earnings and trade upheaval.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Genomic Health, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Genomic Health, Inc.

NEW YORK, July 29, 2019 /PRNewswire/ --  WeissLaw LLP  is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Genomic Health, Inc.

Exact Sciences Reaches Deal to Acquire Genomic Health for $2.8 Billion

Exact Sciences Reaches Deal to Acquire Genomic Health for $2.8 Billion

Cancer diagnostics company Exact Sciences will acquire healthcare company Genomic Health for about $2.8 billion.

Beyond Meat, Pfizer, Mylan, Amazon, Federal Reserve - 5 Things You Must Know

Beyond Meat, Pfizer, Mylan, Amazon, Federal Reserve - 5 Things You Must Know

U.S. stock futures are mixed as Wall Street prepares for a likely quarter-point rate cut from the Federal Reserve; Beyond Meat reports earnings on Monday; Pfizer will combine its off-patent drugs business with Mylan; Exact Sciences reportedly is in negotiations to buy Genomic Health.

Second-quarter Revenue Increased 94 Percent To $200 Million And Cologuard Test Volume Increased 93 Percent To 415,000

Second-quarter Revenue Increased 94 Percent To $200 Million And Cologuard Test Volume Increased 93 Percent To 415,000

- Estimated Cologuard® market share increased to 5.7 percent during the second quarter

Exact Sciences And Genomic Health To Combine, Creating Leading Global Cancer Diagnostics Company

Exact Sciences And Genomic Health To Combine, Creating Leading Global Cancer Diagnostics Company

Joins two of the strongest brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth

Exact Sciences in Talks to Buy Genomic Health - Report

Exact Sciences in Talks to Buy Genomic Health - Report

Cancer diagnostics company Exact Sciences is in advanced talks to acquire Genomic Health for about $2.8 billion to strengthen its cancer-testing offerings, according to Bloomberg.

Exact Sciences Designated A Great Place To Work-Certified™ Company In 2019

Exact Sciences Designated A Great Place To Work-Certified™ Company In 2019

Hundreds of open positions offer opportunity to join growing company

Exact Sciences To Host Annual Meeting, Second-quarter 2019 Results Webcasts And Calls

Exact Sciences To Host Annual Meeting, Second-quarter 2019 Results Webcasts And Calls

MADISON, Wis., July 9, 2019 /PRNewswire/ -- Exact Sciences Corp.

Exact Sciences Advances Fight Against Colorectal Cancer With Opening Of New Laboratory

Exact Sciences Advances Fight Against Colorectal Cancer With Opening Of New Laboratory

Company's total lab processing capacity expected to reach 7 million by end of year

Wendy's, Zoetis, New Age Beverages: 'Mad Money' Lightning Round

Wendy's, Zoetis, New Age Beverages: 'Mad Money' Lightning Round

A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.

Trump's Change of Heart: Cramer's 'Mad Money' Recap (Monday 6/3/19)

Trump's Change of Heart: Cramer's 'Mad Money' Recap (Monday 6/3/19)

By going after friendly trading partners and big tech Trump is forcing Wall Street to re-calibrate and lower valuations, Jim Cramer says.

Exact Sciences To Participate In June Investor Conferences

Exact Sciences To Participate In June Investor Conferences

MADISON, Wis., May 31, 2019 /PRNewswire/ -- Exact Sciences Corp.

Exact Sciences Advances Pipeline Capabilities With Mayo Clinic

Exact Sciences Advances Pipeline Capabilities With Mayo Clinic

Early data on pancreatic cancer detection presented at Digestive Disease Week® 2019

TheStreet Quant Rating: C- (Hold)